Prelude Therapeutics (PRLD) Stock Chart & Stock Price History → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free PRLD Stock Alerts $4.00 -0.28 (-6.54%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Prelude Therapeutics Stock Price Performance5 Day Performance+5.26%1 Month Performance+16.28%3 Month Performance-13.61%6 Month Performance+11.11%Year-To-Date Performance-6.32%1 Year Performance-28.32% Receive PRLD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. PRLD Stock Chart for Saturday, May, 18, 2024 PRLD Chart by TradingView Prelude Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/17/2024$4.28$4.00-6.54%$4.37$3.9940,740 shs$168.32 million05/16/2024$4.00$4.28+7.00%$4.42$3.8651,688 shs$180.10 million05/15/2024$3.86$4.00+3.63%$4.21$3.8448,088 shs$168.32 million05/14/2024$3.80$3.86+1.58%$4.06$3.7227,733 shs$162.43 million05/13/2024$3.73$3.80+1.88%$3.95$3.7521,629 shs$159.90 million05/10/2024$4.07$3.73-8.35%$4.04$3.6953,678 shs$156.96 million Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/09/2024$3.59$4.07+13.37%$4.08$3.6252,898 shs$171.27 million05/08/2024$3.70$3.59-2.97%$3.93$3.5941,344 shs$151.07 million05/07/2024$3.83$3.70-3.39%$4.12$3.6636,872 shs$155.70 million05/06/2024$3.86$3.83-0.78%$4.06$3.8322,713 shs$161.17 million05/03/2024$3.99$3.86-3.26%$4.11$3.8017,251 shs$162.43 million05/02/2024$3.73$3.99+6.97%$4.02$3.7527,359 shs$167.90 million05/01/2024$3.77$3.73-1.06%$3.80$3.6522,025 shs$156.96 million04/30/2024$3.84$3.77-1.82%$3.86$3.5648,436 shs$207.05 million04/29/2024$4.07$3.84-5.65%$4.09$3.8118,176 shs$210.89 million04/26/2024$4.04$4.07+0.74%$4.07$3.9918,543 shs$223.52 million04/25/2024$3.87$4.04+4.39%$4.09$3.99115,736 shs$221.88 million04/24/2024$3.87$3.87$4.13$3.8728,584 shs$212.54 million04/23/2024$3.85$3.87+0.52%$4.07$3.8724,900 shs$212.54 million04/22/2024$3.72$3.85+3.49%$3.96$3.7550,051 shs$211.44 million04/19/2024$3.44$3.72+8.14%$3.86$3.4557,895 shs$204.30 million04/18/2024$4.18$3.44-17.70%$4.18$3.42112,889 shs$188.93 million04/17/2024$4.91$4.18-14.87%$4.92$4.1268,936 shs$229.57 million04/16/2024$5.63$4.91-12.79%$5.63$4.7938,328 shs$269.66 million04/15/2024$5.62$5.63+0.18%$5.83$5.4289,987 shs$309.20 million04/12/2024$5.22$5.62+7.66%$5.77$5.1257,997 shs$308.66 million04/11/2024$4.95$5.22+5.45%$5.35$4.8645,169 shs$286.68 million04/10/2024$4.99$4.95-0.80%$5.17$4.6724,121 shs$271.85 million04/09/2024$4.70$4.99+6.17%$5.07$4.5664,215 shs$274.05 million04/08/2024$4.70$4.70$4.82$4.6015,589 shs$258.12 million04/05/2024$4.74$4.70-0.84%$4.98$4.4717,673 shs$258.12 million04/04/2024$4.72$4.74+0.42%$4.84$4.5821,812 shs$260.32 million04/03/2024$4.62$4.72+2.16%$4.76$4.5228,329 shs$259.22 million04/02/2024$4.69$4.62-1.49%$4.65$4.4131,906 shs$253.73 million04/01/2024$4.74$4.69-1.05%$4.93$4.6114,339 shs$257.58 million03/29/2024$4.74$4.74$5.00$4.7232,074 shs$260.32 million03/28/2024$4.77$4.74-0.63%$5.00$4.7232,074 shs$260.32 million03/27/2024$4.61$4.77+3.47%$4.92$4.5633,947 shs$261.97 million03/26/2024$4.61$4.61$4.82$4.4927,359 shs$253.18 million03/25/2024$4.70$4.61-1.91%$4.92$4.5335,697 shs$253.18 millionTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late.03/22/2024$4.82$4.70-2.49%$4.89$4.6428,969 shs$258.12 million03/21/2024$4.84$4.82-0.41%$4.98$4.7528,586 shs$264.71 million03/20/2024$4.84$4.84$4.94$4.7427,161 shs$265.81 million03/19/2024$4.65$4.84+4.09%$4.94$4.5448,078 shs$265.81 million03/18/2024$4.74$4.65-1.90%$4.92$4.6145,520 shs$255.38 million03/15/2024$4.46$4.74+6.28%$4.75$4.22142,906 shs$260.32 million03/14/2024$4.62$4.46-3.46%$4.63$4.3625,124 shs$244.95 million03/13/2024$4.10$4.62+12.68%$4.66$4.1742,446 shs$253.74 million03/12/2024$4.09$4.10+0.24%$4.19$3.9244,275 shs$225.17 million03/11/2024$4.42$4.09-7.47%$4.42$4.0960,577 shs$224.62 million03/08/2024$4.38$4.42+0.91%$4.45$4.2830,060 shs$242.75 million03/07/2024$4.17$4.38+5.04%$4.45$4.1572,627 shs$240.55 million03/06/2024$4.15$4.17+0.48%$4.45$3.8849,392 shs$229.02 million03/05/2024$4.25$4.15-2.35%$4.25$4.0737,449 shs$227.92 million03/04/2024$4.59$4.25-7.41%$4.67$4.1261,276 shs$233.41 million03/01/2024$4.30$4.59+6.74%$4.63$4.0462,325 shs$252.08 million02/29/2024$4.17$4.30+3.12%$4.48$4.1375,601 shs$236.16 million02/28/2024$4.19$4.17-0.48%$4.25$4.0555,375 shs$229.02 million02/27/2024$4.09$4.19+2.44%$4.49$3.7692,427 shs$230.12 million02/26/2024$3.96$4.09+3.28%$4.19$3.9751,380 shs$224.62 million02/23/2024$3.87$3.96+2.33%$4.05$3.60157,891 shs$217.48 million02/22/2024$3.78$3.87+2.38%$3.93$3.42132,309 shs$212.54 million02/21/2024$4.16$3.78-9.13%$4.33$3.6686,720 shs$207.60 million02/20/2024$4.63$4.16-10.15%$4.56$3.85175,925 shs$228.47 million02/19/2024$4.63$4.63$4.75$3.49433,500 shs$254.28 million Related Companies: scPharmaceuticals Stock Price Chart ProQR Therapeutics Stock Price Chart Capricor Therapeutics Stock Price Chart Gossamer Bio Stock Price Chart Rigel Pharmaceuticals Stock Price Chart Repare Therapeutics Stock Price Chart Alimera Sciences Stock Price Chart CervoMed Stock Price Chart CytomX Therapeutics Stock Price Chart Skye Bioscience Stock Price Chart Receive PRLD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRLD) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.